4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-013544
Options or other derivatives
- President and CEO acquired 249,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Mack David Henry President and CEO | 2022-02-10 | Grant or award · Employee Stock Option (right to buy) | +249,600 | 249,600 | D | ||
Loading xslF345X03/doc4.xml…